Literature DB >> 26375025

Iron restriction in sickle cell anemia: Time for controlled clinical studies.

Oswaldo Castro1, Gregory J Kato2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26375025     DOI： 10.1002/ajh.24193

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.

Authors:  Simon Grootendorst; Jonathan de Wilde; Birgit van Dooijeweert; Annelies van Vuren; Wouter van Solinge; Roger Schutgens; Richard van Wijk; Marije Bartels
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

Review 2.  Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease.

Authors:  Yelena Z Ginzburg; Jeffrey Glassberg
Journal:  EBioMedicine       Date:  2018-07-31       Impact factor: 8.143

3.  Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania.

Authors:  Nathaniel Lee; Julie Makani; Furahini Tluway; Abel Makubi; Andrew E Armitage; Sant-Rayn Pasricha; Hal Drakesmith; Andrew M Prentice; Sharon E Cox
Journal:  EBioMedicine       Date:  2018-07-25       Impact factor: 8.143
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.